| 000 | 01864 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515074436.0 | ||
| 264 | 0 | _c20080117 | |
| 008 | 200801s 0 0 eng d | ||
| 022 | _a0162-0134 | ||
| 024 | 7 |
_a10.1016/j.jinorgbio.2007.05.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGarza-Ortiz, Ariadna | |
| 245 | 0 | 0 |
_aThe synthesis, chemical and biological properties of dichlorido(azpy)gold(III) chloride (azpy=2-(phenylazo)pyridine) and the gold-induced conversion of the azpy ligand to the chloride of the novel tricyclic pyrido[2,1-c][1,2,4]benzotriazin-11-ium cation. _h[electronic resource] |
| 260 |
_bJournal of inorganic biochemistry _cNov 2007 |
||
| 300 |
_a1922-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCisplatin _xpharmacology |
| 650 | 0 | 4 | _aCyclization |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 |
_aGold _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aOrganogold Compounds _xchemical synthesis |
| 650 | 0 | 4 |
_aPyridines _xchemistry |
| 650 | 0 | 4 | _aSpectrometry, Mass, Electrospray Ionization |
| 650 | 0 | 4 | _aSpectrophotometry, Infrared |
| 650 | 0 | 4 | _aSpectrophotometry, Ultraviolet |
| 700 | 1 | _aden Dulk, Hans | |
| 700 | 1 | _aBrouwer, Jaap | |
| 700 | 1 | _aKooijman, Huub | |
| 700 | 1 | _aSpek, Anthony L | |
| 700 | 1 | _aReedijk, Jan | |
| 773 | 0 |
_tJournal of inorganic biochemistry _gvol. 101 _gno. 11-12 _gp. 1922-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jinorgbio.2007.05.008 _zAvailable from publisher's website |
| 999 |
_c17171901 _d17171901 |
||